Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model

Journal of the American Society of Nephrology

Volumn 15, Issue 10, 2004, Pages 2619-2629

  Kelly, Darren J ^a,b   Zhang, Yuan ^a   Gow, Renae ^a   Gilbert, Richard E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; TRANILAST; TRANSFORMING GROWTH FACTOR BETA; ANTHRANILIC ACID DERIVATIVE; COMPLEMENTARY DNA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; GLOMERULOSCLEROSIS; HYPERTENSION; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE; MACROPHAGE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CELL PROLIFERATION; COMPARATIVE STUDY; FOCAL GLOMERULOSCLEROSIS; GENETICS; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE NECROSIS; MOLECULAR GENETICS; NICK END LABELING; NUCLEOTIDE SEQUENCE; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PROBABILITY; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTHRANILIC ACIDS; APOPTOSIS; BASE SEQUENCE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; MOLECULAR SEQUENCE DATA; NEPHRECTOMY; ORGAN CULTURE TECHNIQUES; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 16644370226     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000139066.77892.04     Document Type: Article

References (50)

1. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20: 1-17, 1992
2. Mauer S, Steffes M, Ellis E, Sutherland D, Brown D, Goetz F: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143-1155, 1984
3. Border WA, Brees D, Noble NA: Transforming growth factor-beta and extracellular matrix deposition in the kidney. Contrib Nephrol 107: 140-145, 1994
4. Shigeki S, Murakami T, Yata N, Ikuta Y: Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of tranilast. Scand J Plast Reconstr Surg Hand Surg 31: 151-158, 1997
5. Taniguchi S, Yorifuji T, Hamada T: Treatment of linear localized scleroderma with the anti-allergic drug, tranilast. Clin Exp Dermatol 19: 391-393, 1994
6. Yamada H, Tajima S, Nishikawa T, Murad S, Pinnell SR: Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem (Tokyo) 116: 892-897, 1994
7. Ikeda H, Inao M, Fujiwara K: Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells. Biochem Biophys Res Commun 227: 322-327, 1996
8. Miyazawa K, Kikuchi S, Fukuyama J, Hamano S, Ujiie A: Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 118: 213-221, 1995
9. Mifsud S, Kelly, Qi W, Zhang Y, Pollock CA, Wilkinson-Berka JL, Gilbert RE: Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy. Nephron 95: 83-91, 2003
10. Wu L, Cox A, Roe C, Dziadek M, Cooper ME, Gilbert RE: Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system. Kidney Int 51: 1553-1567, 1997
11. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647-655, 1983
12. Bunag RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34: 279-282, 1973
13. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat. Kidney Int 54: 343-352, 1998
14. Masson P: Trichrome stainings and their preliminary technique. J Tech Methods 2: 75-90, 1929
15. Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berka JL, Gilbert RE: Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 61: 31-39, 2002
16. Haller D, Holt L, Kim SC, Schwabe RF, Sartor RB, Jobin C: Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J Biol Chem 278: 23851-23860, 2003
17. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM: Application of Photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45: 1559-1565, 1997
18. Lehr HA, van der Loos CM, Teeling P, Gown AM: Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 47: 119-126, 1999
19. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991
20. Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berka JL, Gilbert RE: Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 61: 31-39, 2002
21. Wilkinson-Berka JL, Babic S, De Gooyer T, Stitt AW, Jaworski K, Ong LG, Kelly DJ, Gilbert RE: Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. Am J Pathol 164: 1263-1273, 2004
22. Kelly DJ, Aaltonen P, Cox AJ, Rumble JR, Langham R, Panagiotopoulos S, Jerums G, Holthofer H, Gilbert RE: Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: Differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 17: 1327-1332, 2002
23. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97: 8015-8020, 2000
24. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346: 281-284, 1990
25. Pinto YM, Pinto-Sietsma SJ, Philipp T, Engler S, Kobetamehl P, Hocher B, Marquardt H, Sethmann S, Lauster R, Merker HJ, Paul M: Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat. Hypertension 36: 747-754, 2000
26. Miyajima A, Asano T, Yoshimura I, Seta K, Hayakawa M: Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol 165: 1714-1718, 2001
27. Ward MR, Sasahara T, Agrotis A, Dilley RJ, Jennings GL, Bobik A: Inhibitory effects of tranilast on expression of transforming growth factor-β isoforms and receptors in injured arteries. Atherosclerosis 137: 267-275, 1998
28. Soma J, Sugawara T, Huang YD, Nakajima J, Kawamura M: Tranilast slows the progression of advanced diabetic nephropathy. Nephron 92: 693-698, 2002
29. Taft J, Nolan CJ, Yeung SP, Hewitson TD, Martin FIR: Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 43: 1046-1051, 1994
30. Cordonnier DJ, Pinel N, Barro C, Maynard C, Zaoui P, Halimi S, De Ligny BH, Reznic Y, Simon D, Bilous RW: Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. J Am Soc Nephrol 10: 1253-1263, 1999
31. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998
32. Malyankar UM, Almeida M, Johnson RJ, Pichler RH, Giachelli CM: Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int 51: 1766-1773, 1997
33. Sato K, Kawasaki H, Nagayama H, Enomoto M, Morimoto C, Tadokoro K, Juji T, Takahashi TA: TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol 164: 2285-2295, 2000
34. Kaissling B, Lehir M: Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int 45: 709-720, 1994
35. Nikolic-Paterson DJ, Lan HY, Hill PA, Atkins RC: Macrophages in renal injury. Kidney Int Suppl 45: S79-S82, 1994
36. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Takeda SI, Takasawa K, Yoshimura M, Kida H, Kobayashi KI, Mukaida N, Naito T, Matsushima K, Yokoyama H: Upregulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58: 1492-1499, 2000
37. Shikata K, Makino H: Role of macrophages in the pathogenesis of diabetic nephropathy. Contrib Nephrol (134): 46-54, 2001
38. Schena FP, Gesualdo L, Grandaliano G, Montinaro V: Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game? Kidney Int 52: 1439-1457, 1997
39. Risdon RA, Sloper JC, de Vardener HE: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 2: 363-366, 1968
40. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural-functional correlations in renia disease. Part II. The correlations. Hum Pathol 1: 631-641, 1970
41. Schelling JR, Cleveland RP: Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. Kidney Int 56: 1313-1316, 1999
42. Schelling JR, Nkemere N, Kopp JB, Cleveland RP: Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 78: 813-824, 1998
43. Choi ME, Ballermann BJ: Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors. J Biol Chem 270: 21144-21150, 1995
44. Rotello RJ, Lieberman RC, Purchio AF, Gerschenson LE: Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc Natl Acad Sci U S A 88: 3412-3415, 1991
45. Sanchez A, Alvarez AM, Benito M, Fabregat I: Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: Involvement of reactive oxygen intermediates. J Biol Chem 271: 7416-7422, 1996
46. Soto K, Gomez-Garre D, Largo R, Gallego-Delgado J, Tejera N, Catalan MP, Ortiz A, Plaza JJ, Alonso C, Egido J: Tight blood pressure control decreases apoptosis during renal damage. Kidney Int 65: 811-822, 2004
47. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992
48. Schiffer M, von Gersdorff G, Bitzer M, Susztak K, Bottinger EP: Smad proteins and transforming growth factor-beta signaling. Kidney Int Suppl 77: S45-S52, 2000
49. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 14: 627-644, 2000
50. Ochiai H, Ochiai Y, Chihara E: Tranilast inhibits TGF-A1 secretion without affecting its mRNA levels in conjunctival cells. Kobe J Med Sci 47: 203-209, 2001